Gemcitabine Hydrochloride | 1759

A nucleoside analog of deoxycytidine used in chemotherapy to treat various types of cancer. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.

Gemcitabine Hydrochloride is a nucleoside analog of deoxycytidine used in chemotherapy to treat various types of cancer.

1759 | Gemcitabine Hydrochloride DataSheet

Alternate Name/Synonyms: 2′,2′-difluoro-2′-deoxycytidine; Gamcitabine; Gemcitera; Gemsar; Gemzar; LY-188012

Appearance: White solid

Formulation: N/A

CAS Number: 122111-03-9

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₉H₁₁F₂N₃O₄•HCl

Molecular Weight: 299.66

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (10 mg/ml) or H₂O (25 mg/ml)

Handling: Protect from air and moisture

Country of Origin: USA

Tag Line: An anticancer agent

MDL Number: MFCD01735988

PubChem CID: 60749

SMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl

InChi: InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8 (14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/m1./s1

InChi Key: OKKDEIYWILRZIA-OSZBKLCCSA-N